GU
₹416.50
-2.50(-0.60%)
GUFICBIO₹416.50-0.60%
64/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %GUFICBIO financial summary
For Mar 2026, Gufic Biosciences Limited reported revenue of ₹940 crore, which grew 14.6% from the previous year. Net profit was ₹63 crore, which fell 10.0% year on year, on an operating margin of 16%. Earnings per share came in at ₹6.3. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹940 crore |
|---|---|
| Net profit | ₹63 crore |
| Operating margin | 16% |
| EPS | ₹6.3 |